Loading...
Circulating miR-23b as a Novel Biomarker for Early Risk Stratification After ST-Elevation Myocardial Infarction
BACKGROUND: miR-23b overexpression can promote cardiomyocyte apoptosis and reduce cell growth under hypoxic conditions, suggesting that miR-23b acts as a biomarker for ST-elevation myocardial infarction (STEMI). The aim of this study was to investigate the effect of miR-23b on STEMI patients. MATERI...
Saved in:
| Published in: | Med Sci Monit |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
International Scientific Literature, Inc.
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5866732/ https://ncbi.nlm.nih.gov/pubmed/29535290 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.908060 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|